Related Experiment Video
Updated: Jan 22, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data
Klaus Geissler1,2, Eva Jäger3, Agnes Barna4
1Sigmund Freud University, Vienna, Austria. klaus.geissler@wienkav.at.
Insights
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) captures real-world data, confirming its value for research. This study validates prognostic markers and highlights differences between myeloproliferative and myelodysplastic subtypes of CMML.
Area of Science:
- Hematology
- Oncology
- Genomics
- Clinical Research
Background:
- Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy with complex biology.
- Large, comprehensive real-world datasets are crucial for understanding CMML heterogeneity and improving patient outcomes.
- The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) offers a unique combination of clinical, functional, and molecular data.
Purpose of the Study:
- To assess the representativeness of the ABCMML cohort by comparing its clinicolaboratory characteristics with international CMML cohorts.
- To validate established prognostic parameters within the ABCMML dataset.
- To investigate phenotypic and genotypic differences between myeloproliferative (MP) and myelodysplastic (MD) subtypes of CMML.
Main Methods:
- Retrospective analysis of clinicolaboratory data from 531 CMML patients (excluding those in transformation) within the ABCMML.
- Comparison of patient characteristics (age, blood counts, LDH, blasts) with published CMML cohorts.
- Evaluation of established prognostic parameters (leukocytes, hemoglobin, blasts, cytogenetics) for outcome discrimination.
- Analysis of differences between MP-CMML and MD-CMML, including molecular mutations (e.g., RAS-pathway), in vitro colony growth, and clinical features (e.g., splenomegaly).
Main Results:
- The ABCMML cohort's median values for key clinicolaboratory parameters align with reported CMML series, indicating representativeness.
- Established prognostic markers effectively discriminated patient outcomes within the ABCMML cohort.
- MP-CMML patients exhibited distinct features compared to MD-CMML, including higher blast counts, elevated LDH, RAS-pathway mutations, increased spontaneous myelomonocytic colony growth, and higher incidence of splenomegaly.
Conclusions:
- The ABCMML is a valuable and representative real-world data source for CMML research.
- The study confirms the utility of established prognostic parameters in this cohort.
- Significant clinicolaboratory and molecular differences between MP-CMML and MD-CMML subtypes are confirmed, supporting distinct biological entities.
Abstract:
In the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) clinicolaboratory real-life data have been captured from 606 CMML patients from 14 different hospitals over the last 30 years. It is the only large biodatabase worldwide in which functional methods such as semisolid in vitro cultures complement modern molecular methods such as next generation sequencing. This provides the possibility to comprehensively study the biology of CMML. The aim of this study was to compare patient characteristics with published CMML cohorts and to validate established prognostic parameters in order to examine if this real-life database can serve as a representative and useful data source for further research. After exclusion of patients in transformation characteristics of 531 patients were compared with published CMML cohorts. Median values for age, leukocytes, hemoglobin, platelets, lactate dehydrogenase (LDH) and circulating blasts were within the ranges of reported CMML series. Established prognostic parameters including leukocytes, hemoglobin, blasts and adverse cytogenetics were able to discriminate patients with different outcome. Myeloproliferative (MP) as compared to myelodysplastic (MD)-CMML patients had higher values for circulating blasts, LDH, RAS-pathway mutations and for spontaneous myelomonocytic colony growth in vitro as well as more often splenomegaly. This study demonstrates that the patient cohort of the ABCMML shares clinicolaboratory characteristics with reported CMML cohorts from other countries and confirms phenotypic and genotypic differences between MP-CMML and MD-CMML. Therefore, results obtained from molecular and biological analyses using material from the national cohort will also be applicable to other CMML series and thus may have a more general significance.
Related Concept Videos
The Representativeness Heuristic
GIS Software, Hardware, and Sources of GIS Data
Half-life of a Reaction
Characteristics of Life
The Angiosperm Life Cycle
The Tree of Life - Bacteria, Archaea, Eukaryotes

